Dergiler / The European Research Journal / 2016 / Cilt: 2 - Sayı: 1

Evaluation of Tp-e interval and Tp-e/ QTc ratio in patients with mild to moderate psoriasis

Sayfa
46–51
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Thesefindings suggest that ventricular repolarization in mild to moderate psoriasis patients might be unimpaired.Larger samples and severe degree psoriasis patients are needed to evaluate the arrhythmia risk in psoriasis patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Many systemic diseases including cardiovascular disturbances have been described in psoriaticpatients.
📊
Temel Bulgular & Veri:In this study, retrospective analysis of 30 patients who underwent thepsoriasis treatment and of 30 healthy individuals was performed.
💡
Sonuç & Katkı:Thesefindings suggest that ventricular repolarization in mild to moderate psoriasis patients might be unimpaired.Larger samples and severe degree psoriasis patients are needed to evaluate the arrhythmia risk in psoriasis patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives. Many systemic diseases including cardiovascular disturbances have been described in psoriaticpatients. In the previous studies, left ventricle (LV) subclinical myocardial dysfunction was reported in thepsoriasis patients. The T-wave peak to end (Tp-e) interval is a relatively new marker for ventriculararrhythmogenesis and repolarization heterogeneity. Prolongation of this interval represents a period of potentialvulnerability to ventricular arrhythmias. However, there is no information available assessing the Tp-e intervaland related calculations in patients with psoriasis disease. The aim of this study was to evaluate ventricularrepolarization in patients with psoriasis disease by using QT, corrected QT (QTc) and Tp-e interval, Tp-e/QTratio, and Tp-e/QTc ratio. Methods. In this study, retrospective analysis of 30 patients who underwent thepsoriasis treatment and of 30 healthy individuals was performed. The severity of the disease was evaluated bythe "Psoriasis Area and Severity Index". QT, corrected QT (QTc), Tp-e interval and Tp-e/QT ratio weremeasured by means of the 12-lead electrocardiogram. Left ventricular function was evaluated byechocardiography. Results. Baseline characteristics and QT and QTc intervals were similar in both groups. Nodifference was detected between the groups with regards to Tp-e interval (83.0±9 vs 82.3±10; p=0.81), Tpe/QT (0.22±0.03 vs 0.23±0.04; p=0.3) and Tp-Te/QTc (0.20±0.04 vs 0.19±0.04; p=0.77). Conclusions. Thesefindings suggest that ventricular repolarization in mild to moderate psoriasis patients might be unimpaired.Larger samples and severe degree psoriasis patients are needed to evaluate the arrhythmia risk in psoriasis patients.

🔖

Bu Makaleye Atıf Yap

PEKER, T., KANAT, S., VATANSEVER, F., TENEKECİOGLU, E., KARAAGAC, K., OZLUK, O. A., TOPAL, D., BOYRAZ, B., YİLMAZ, M. (2022). Evaluation of Tp-e interval and Tp-e/ QTc ratio in patients with mild to moderate psoriasis. The European Research Journal, Cilt: 2 - Sayı: 1, 46–51. https://ajindex.com/articles/597803

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013 Feb;133(2):377-85.
  2. Tseng HW, Lin HS, Lam HC. Co-morbidities in psoriasis: a hospital-based case-control study. J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1417-25.
  3. Ryan C, Menter A. Psoriasis and cardiovascular disorders. G Ital Dermatol Venereol. 2012 Apr;147(2):179-87.
  4. Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012;225(2):121-6.
  5. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010 Apr;31(8):1000- 6. Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, et al. High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol. 2011 Jul;38(7):1363-70.
  6. Shang Q, Tam LS, Sanderson JE, Sun JP, Li EK, Yu CM. Increase in ventricular-arterial stiffness in patients with psoriatic arthritis. Rheumatology (Oxford). 2012 Dec;51(12):2215-23.
  7. Zhao CT, Yeung CK, Siu CW, Tam S, Chan J, Chen Y, et al. Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis. J Eur Acad Dermatol Venereol. 2014 Apr;28(4):461-8.
  8. Smetana P, Schmidt A, Zabel M, Hnatkova K, Franz M, Huber, et al. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. J Electrocardiol. 2011 May-Jun;44 (3):301-8.
  9. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008 Nov-Dec;41(6):567-74.
  10. Louden BA, Pearce DJ, Lang W, Feldman SR. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J. 2004 Oct 15;10(2):7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ermande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update form the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70. Castro Hevia